Genetic ablation of dominant CaMKII isoforms in the heart attenuates cardiac hypertrophy or the transition to cardiac dysfunction after pressure overload (Zhang et al., 2003; Backs et al., 2009; Ling et al., 2009). This evidence concerns the gene CAMK2G and cardiac hypertrophy.